SCHEMBL3846827

SCHEMBL3846827

Brc1ccc2ncc(-c3ccccn3)n2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K14 Q99558 1/20 0.59
FLT3 P36888 2/20 0.52
PIK3CA P42336 2/20 0.46
MTOR P42345 2/20 0.46
KDM4E B2RXH2 2/20 0.43
GAA P10253 2/20 0.43
NPC1 O15118 2/20 0.43
TP53 P04637 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
ALOX15 P16050 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
GABRA1 P14867 1/20 0.42
GABRG2 P18507 1/20 0.42
GABRB3 P28472 1/20 0.42
GABRA3 P34903 1/20 0.42
CHEK1 O14757 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19585798 0.82 MAP3K14 (0.56) MAP3K14FLT3PIK3CAMTORCHEK1
SCHEMBL15756965 0.80 MAP3K14 (0.54) MAP3K14FLT3PIK3CAMTORCHEK1
SCHEMBL1615002 0.80 MAP3K14 (0.62) MAP3K14FLT3PIK3CAMTORCHEK1
SCHEMBL26178953 0.78 KDR (0.53) MAP3K14FLT3PIK3CAMTORNPC1
SCHEMBL4254179 0.76 MAP3K14 (0.56) MAP3K14FLT3PIK3CAMTORGAA
SCHEMBL1614011 0.75 MAP3K14 (1.00) MAP3K14FLT3PIK3CAMTORGSK3B
SCHEMBL3491081 0.74 TGFBR1 (0.46) FLT3KDM4EGAANPC1SMN1; SMN2
SCHEMBL19586833 0.73 PIK3CA (0.50) MAP3K14FLT3PIK3CAMTORCHEK1
SCHEMBL3491776 0.73 IRAK4 (0.47) FLT3KDM4EGAANPC1SMN1; SMN2
SCHEMBL15288131 0.71 FYN (0.55) MAP3K14FLT3PIK3CAMTORKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed